POSTER SESSION VI
Wednesday, March 24, 2010 — 1:00 PM - 4:00 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Mutational Profiling of Phyllodes Tumors
(243)
VB Korcheva, J Levine, C Beadling, A Warrick, N Olson, M Heinrich, CL Corless, ML Troxell - Oregon Health and Science University, Portland, OR; Kaiser Permanente, Portland, OR
Epithelial-Mesenchymal Transition in Breast Carcinomas
(230)
H Jeong, Y Ryu, J An, Y Lee, A Kim - Korea University Guro Hospital, Seoul, Korea, Seoul, Korea; Samsung Medical Center, Seoul, Kyrgyzstan
IKBKE, NFkB and HIF1A Activation in TLR-9 Invasive Ductal Carcinomas: Relationship with Epithelio-Mesenchymal Transition
(269)
D Meseure, F Lerebours, K Drak-Alsibai, M Trassard, V Suciu, C Andre, C Le Ray, S Vacher, R Lidereau, JM Guinebretiere, I Bieche - Centre Rene Huguenin, St Cloud, France; Institut Andre Godinot, Reims, France
Mutations in PIK3CA Lymph Node-Positive Breast Carcinomas Are Associated with Luminal Immunophenotype
(146)
FI Aranda, L Sanchez-Tejada, C Alenda, G Peiro, J Segui, M Niveiro, A Paya, JB Laforga, E de Alava, J Palacios, M Martin - Hospital General Universitario, Alicante, Spain; Centro Investigacion del Cancer, Salamanca, Spain; Hospital Virgen del Rocio, Sevilla, Spain; GEICAM, Madrid, Spain
Association of PIK3CA Mutations in Exon 9 with Luminal Immunophenotype Breast Carcinoma
(305)
L Sanchez-Tejada, FJ Gutierrez-Avino, FI Aranda, J Segui, E Lerma, D Giner, G Peiro - Hospital General Universitari, Alacant, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Expression Profile of Matrix Metalloproteinases in Primary and Metastatic Breast Cancer
(328)
M Tretiakova, NV Kaverina, P Pytel, ZG Kadagidze, AY Baryshnikov, IV Ulasov, MS Lesniak - University of Chicago, Chicago; NN Blokhin Russian Oncology Center, Moscow, Russian Federation
Variations in Stromal Signatures in Breast Cancer Metastases
(335)
JA Webster, AH Beck, M Sharma, I Espinosa, M Schreuder, KD Montgomery, KC Jensen, M van de Rijn, RB West - Stanford University, Stanford, CA; Palo Alto Veterans Administration Hospital, Palo Alto, CA
Invasion and Cancer Stem Cell Biomarkers Can Predict Breast Cancer Metastasis
(133)
E Adler, M Oktay, R Stobezki, F Gertler, J Condeelis, J Jones, S Goswami - Montefiore Medical Center, Bronx, NY; Yeshiva University, New York, NY; Massachussetts Institute of Technology, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY; Weill Cornell Medical College, New York, NY
Tumor Size, Nuclear Grade and HER2 Positivity Predict Lymph Node Metastasis in Breast Carcinomas That Have Lymphovascular Invasion
(347)
X Xiao, J Wang, P Petry, T Albrecht, S Xu, DG Hicks, K Skinner, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Research Triangle Park, NC
Immunohistochemical Identification of a Metastasis Modifier Gene (Rrp1b) in Breast Cancer May Help Identify Tumors with High Metastatic Potential
(140)
FZ Aly, B Walter Rodriguez, MJ Merino - National Cancer Institute, National Institutes of Health, Bethesda
CXCL12/CXCR4 Transcripts Levels of Expression Are Linked to Distant Metastasis and DFS Outcome in Breast Carcinoma
(301)
A Rouquette, M Cornic, E Blot, JM Picquenot, S Laberge-Le Couteulx - CRLCC Henri Becquerel, Rouen, France
Piwil2-Like Proteins Are a Potential Biomarker for Breast Cancer Progression
(310)
RL Shen, G He, C Shapiro, JJ Li, L Chen, Y Ye, SH Barsky, JX Gao - Ohio State University, Columbus, OH; Ohio State University Medical Center, Columbus, OH; UC Davis Cancer Center, Sacramento, CA
Downregulation of Hematopoietic Progenitor Kinase 1 Protein Level in Ductal Carcinoma In Situ and Invasive Ductal Carcinoma of Breast
(167)
S Chen, C Albarracin, H Wang, K Klein, A Sahin, HM Wang - The University of Texas MD Anderson Cancer Center, Houston, TX; The University of Texas at Houston, Houston, TX
SIAH as a Potential Prognostic Marker for Recurrence in Patients with Ductal Carcinoma In Situ
(154)
KC Behling, AH Tang, S Kadiaka, K Nguyen, M Potoczek, SC Peiper, GF Schwartz, AK Witkiewicz - Thomas Jefferson University Hospital, Philadelphia, PA
Development of a Population Based Model for Progression of DCIS to Invasion
(343)
A Wong, P Macklin, YL Chuang, V Cristini, ME Sanders, PA Schuyler, WD Dupont, DL Page, ME Edgerton - The University of Texas at Austin, Austin, TX; University of Texas Health Science Center, Houston, TX; Vanderbilt University School of Medicine, Nashville, TN; UT MD Anderson Cancer Center, Houston, TX
Detection of microRNA-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis
(202)
S Gomez-Macias, BA Walter Rodriguez, VA Valera Romero, M Sobel, MJ Merino - Autonomous University of Nuevo Leon, Monterrey, Mexico; National Cancer Institute, National Institutes of Health, Bethesda
Correlation of CCND1 Amplification with Hormone Receptor (ER, PR) Expression and ERBB2 (Her2/neu) Gene Amplification in Invasive Ductal Carcinoma of the Breast: A Study of 102 Cases
(165)
MC Chang, IT Ocal, K Taneja, DA Dillon - Brigham & Women's Hospital; Harvard Medical School, Boston, MA; Mayo Clinic, Scottsdale, AZ
Significance of Unamplified Chromosome 17 Monosomy in Breast Carcinoma
(245)
U Krishnamurti, FD Atem, JF Silverman - Western Pennsylvania Hospital, Pittsburgh, PA; Allegheny General Hospital, Pittsburgh, PA; University of Pittsburgh, Pittsburgh, PA
Hepatocyte Growth Factor/Scatter Factor and Its Receptor c-Met Modulate E-Cadherin Expression in Matrix-Producing Breast Carcinomas
(208)
K Gwin, A Acurio, R Buell-Gutbrod - University of Chicago, Chicago, IL
Androgen Receptor Expression Is a Significant Prognostic Factor in Estrogen Receptor Positive Breast Cancers Treated with Chemo-Endocrine Therapy
(163)
I Castellano, E Allia, V Accortanzo, AM Vandone, L Chiusa, R Arisio, A Durando, M Donadio, G Bussolati, AS Coates, G Viale, A Sapino - University of Turin, Turin, Italy; Sant'Anna Hospital, Turin, Italy; Molinette Hospital, Turin, Italy; University of Sydney, Sydney, Australia; European Institute of Oncology, Milan, Italy
Mitotic Grade and MIB-1 Are Not Redundant Measures of Proliferation in Breast Cancer
(162)
J Carter, J Hanson, R Greiner, N Asgarian, J Deschenes, J Mackey, J Hugh - University of Alberta, Edmonton, AB, Canada
Positive Expression of Enhancer of Zeste Homolog 2 Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
(203)
Y Gong, L Huo, N Sneige, M Cristofanilli - The University of Texas M D Anderson Cancer Center, Houston, TX
button next to any title to add to Itinerary Planner...
Add
